William Blair & Company
AGN

William Blair & Company’s Allergan plc AGN Stock Holding History

William Blair & Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,256
Closed -$931K – 1786
2020
Q1 		$931K Buy
5,256
+66
+1% +$12.4K 0.01% 687
2019
Q4 		$992K Sell
5,190
-731
-12% -$132K 0.01% 781
2019
Q3 		$1.87M Sell
5,921
-3,665
-38% -$597K 0.01% 588
2019
Q2 		$3.03M Sell
9,586
-6,848
-42% -$948K 0.02% 472
2019
Q1 		$5.19M Buy
16,434
+455
+3% +$66K 0.03% 354
2018
Q4 		$5.04M Sell
15,979
-9,633
-38% -$1.58M 0.04% 332
2018
Q3 		$4.88M Buy
25,612
+2,301
+10% +$423K 0.03% 375
2018
Q2 		$3.89M Sell
23,311
-5,382
-19% -$864K 0.03% 406
2018
Q1 		$4.83M Sell
28,693
-4,300
-13% -$721K 0.03% 351
2017
Q4 		$5.4M Sell
32,993
-29,701
-47% -$5.33M 0.04% 342
2017
Q3 		$12.8M Sell
62,694
-16,930
-21% -$3.94M 0.1% 205
2017
Q2 		$19.4M Sell
79,624
-6,180
-7% -$1.45M 0.15% 159
2017
Q1 		$20.5M Sell
85,804
-16,180
-16% -$3.77M 0.17% 147
2016
Q4 		$21.4M Sell
101,984
-122,438
-55% -$25.4M 0.19% 130
2016
Q3 		$51.7M Buy
224,422
+159,152
+244% +$38.9M 0.46% 65
2016
Q2 		$15.1M Buy
65,270
+27,142
+71% +$6.26M 0.14% 170
2016
Q1 		$10.2M Buy
38,128
+1,007
+3% +$288K 0.1% 195
2015
Q4 		$11.6M Buy
+37,121
New +$11.1M 0.11% 194
2013
Q4 		– Sell
-15,591
Closed -$2.25M – 2052
2013
Q3 		$2.25M Sell
15,591
-8,520
-35% -$1.13M ﹤0.01% 1098
2013
Q2 		$3.04M Buy
+24,111
New +$2.73M 0.01% 981

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

William Blair & Company's AGN Position: Q2 2020 in Review

William Blair & Company sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,256 shares — an estimated $931K sold.

William Blair & Company first reported a position in AGN in Q2 2013 and held it in 20 quarters. The position peaked at $51.7M in Q3 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • William Blair & Company reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • William Blair & Company sold 5,256 Allergan plc shares in Q2 2020, an estimated $931K.
  • William Blair & Company first reported a position in Allergan plc in Q2 2013 and held it in 20 quarters.
  • William Blair & Company's Allergan plc position peaked at $51.7M in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on William Blair & Company's 13F filing for Q2 2020, filed 12 Aug 2020.